Pharma and life-sciences marketing carries some of the strictest advertising scrutiny of any category — off-label claims, safety information and HCP-targeting rules can turn a well-intentioned campaign into a takedown. BrandEnsure builds every pharma campaign against these rules from the first draft, so creative never has to be reworked after the fact.
These are the recurring compliance categories our Compliance Shield checks on every pharma and life-sciences ad, informed by local drug-advertising codes and platform health-ad policies.
Every efficacy and usage claim is checked against the product's approved indication — no promotion of unapproved uses, however clinically plausible.
Direct-to-consumer prescription content carries the required risk and safety information, sized and positioned per applicable disclosure rules.
Professional-audience content is gated and targeted separately from consumer-facing ads, respecting the different rules each audience is subject to.
Prescription-only products are promoted within the bounds set for that drug class, with required disclaimers never omitted for the sake of a shorter ad.
Creative is re-screened against the destination market's own drug-advertising code before it runs there — rules differ by country and we don't assume one covers all.
Every clinical or statistical claim is traced to a citable source before it appears in an ad, so it can be defended if a regulator or platform asks.
Compliant pharma campaigns don't just avoid risk — they build the clinical and regulatory trust that drives HCP engagement and patient confidence, without the delay of a traditional MLR cycle.
Common mistakes pharma marketers make on social — and the compliant alternative we build into every campaign.
A dedicated compliance specialist and AEGIS work together on every pharma engagement — this is what that looks like in practice.
AEGIS flags any claim that drifts outside the approved label before a human reviewer ever sees the draft.
Required safety information is inserted and formatted automatically for every DTC prescription asset, per channel.
Professional-audience content is targeted and gated separately, so consumer and HCP messaging never cross.
A maintained library of drug-advertising codes per market, checked automatically whenever a campaign crosses borders.
A compliance specialist signs off on every AEGIS-flagged risk before anything publishes — two checks, one approval.
Continuous monitoring for regulator notices or platform flags, with a documented rapid-response process if one appears.
You May Also Be Interested In
Tell us your brand, indication and target markets — we'll show you a sample compliant campaign and a quote, no obligation.
Request a Quote →